Topic: BREAKING: WHO Suspends Trial Of Hydroxychloroquine As COVID-19 Treatment Over Safety Concerns  (Read 2509 times)

0 Members and 2 Guests are viewing this topic.

BREAKING: WHO Suspends Trial Of Hydroxychloroquine As COVID-19 Treatment Over Safety Concerns







The World Health Organisation has suspended testing malaria drug, Hydroxychloroquine, in COVID-19 patients due to safety concerns.


WHO Director-General, Tedros Adhanom Ghebreyesus, in a virtual press conference on Monday, said the decision came after the publication last week of a study indicating that using the drug on COVID-19 patients could increase their likelihood of dying.


Hydroxycholoroquine has been touted by United States President, Donald Trump, and others as a possible treatment for the disease. 









Trump had said he was taking the drug to help prevent infection.


“The executive group has implemented a temporary pause of the Hydroxychloroquine arm within the solidarity trial while the safety data is reviewed by the data safety monitoring board,” Ghebreyesus said.




PUBLIC HEALTH



Breaking News

News





AddThis







Original Author



Saharareporters, New York



Disable advertisements


Source: BREAKING: WHO Suspends Trial Of Hydroxychloroquine As COVID-19 Treatment Over Safety Concerns

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
1499 Views
Last post July 01, 2015, 07:00:55 PM
by olutee
0 Replies
2059 Views
Last post September 08, 2016, 07:00:15 PM
by clowntom
0 Replies
1399 Views
Last post March 31, 2020, 07:05:46 PM
by observer
0 Replies
1718 Views
Last post April 04, 2020, 01:05:15 PM
by sahara
0 Replies
1375 Views
Last post June 06, 2020, 01:09:42 AM
by clowntom
0 Replies
1536 Views
Last post July 30, 2020, 07:01:49 PM
by PulseNG
0 Replies
1106 Views
Last post June 07, 2022, 01:21:53 PM
by NaijaPilot
0 Replies
697 Views
Last post May 25, 2024, 01:02:52 AM
by flukky-1
0 Replies
659 Views
Last post November 26, 2024, 01:03:07 AM
by flukky-2
0 Replies
682 Views
Last post March 15, 2025, 01:05:55 PM
by thisday